Genome-editing-based reverting of the mutant to the wild-type (WT) sequence coupled with survival assays and expression profiling proved that mutations of the iSE deregulate BCL6 levels and conform to addiction in DLBCL phenotype selection. Here, BCL6 is linked to diffuse large B-cell lymphoma.